Velanne Asset Management LTD Takeda Pharmaceutical CO LTD Transaction History

Velanne Asset Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$13.02 - $20.31 $3.94 Million - $6.15 Million	-302,694 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$16.88 - $20.83 $2,430 - $2,999	144 Added 0.05%	302,694 $5.97 Million
Q3 2019 Nov 13, 2019	BUY	$16.15 - $17.99 $256,946 - $286,220	15,910 Added 5.55%	302,550 $5.2 Million
Q2 2019 Jul 29, 2019	BUY	$16.58 - $20.49 $77,395 - $95,647	4,668 Added 1.66%	286,640 $5.07 Million
Q1 2019 Apr 17, 2019	BUY	$16.7 - $21.52 $4.62 Million - $5.96 Million	276,722 Added 5270.9%	281,972 $5.74 Million
Q4 2018 Feb 08, 2019	BUY	$15.64 - $21.1 $82,110 - $110,775	5,250 New	5,250 $88,000

338

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41.3B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Velanne Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Velanne Asset Management LTD with notifications on news.